We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Christopher Hoimes, DO

Showing   of 2 results

Next-Generation Immunotherapy Agents Under Study for Early-Stage Bladder Cancer

The new class of drugs known as immune checkpoint inhibitors, which target molecules that serve as checks and balances in the regulation of immune responses, are proving effective against advanced bladder cancer.

UH Seidman Cancer Center Building Entrance.

Genomics for the Next Generation

New approach at UH Seidman Cancer Center simplifies testing, integrates genomics information with other complex tests    Innovations in Cancer - Winter 2016 Download PDF  Joseph Willis, MD  Christopher Hoimes, MD  Afshin Dowlati, MD ...

Results are loading...